The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis

Objectives: Methylene blue exerts its vasopressor properties by inhibiting nitric oxide-mediated vasodilation. Recent studies have advocated the use of methylene blue as a rescue therapy for patients with septic shock. The primary aim was to investigate the effect of methylene blue on the mean arter...

Full description

Saved in:
Bibliographic Details
Main Authors: Ka Ting Ng, Pei En Kwok, Wei En Lim, Wan Yi Teoh, Mohd Shahnaz Hasan, Mohd Fitry Zainal Abidin
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Brazilian Journal of Anesthesiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0104001424001027
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575510921609216
author Ka Ting Ng
Pei En Kwok
Wei En Lim
Wan Yi Teoh
Mohd Shahnaz Hasan
Mohd Fitry Zainal Abidin
author_facet Ka Ting Ng
Pei En Kwok
Wei En Lim
Wan Yi Teoh
Mohd Shahnaz Hasan
Mohd Fitry Zainal Abidin
author_sort Ka Ting Ng
collection DOAJ
description Objectives: Methylene blue exerts its vasopressor properties by inhibiting nitric oxide-mediated vasodilation. Recent studies have advocated the use of methylene blue as a rescue therapy for patients with septic shock. The primary aim was to investigate the effect of methylene blue on the mean arterial pressure among adult patients with septic shock. Methods: Databases of MEDLINE, EMBASE, and CENTRAL were searched from their inception date until October 2023. Randomized Clinical Trials (RCT) comparing methylene blue and placebo in adults with septic shock were included. Results: Our systematic review included 5 studies (n = 257) for data analysis. As compared to the placebo, our pooled analysis showed that methylene blue significantly increased mean arterial pressure (MD: 1.34 mmHg, 95% CI 0.15 to 2.53, p = 0.03, level of evidence: very low). Patients who were given methylene blue were associated with statistically lower mortality rate (OR = 0.49, 95% CI 0.27 to 0.88, p = 0.02, level of evidence: low), reduced serum lactate levels (MD: -0.76 mmoL.L-1, 95% CI -1.22 to -0.31, p = 0.0009, level of evidence: low), reduced length of hospital stay (MD: -1.94 days, 95% CI -3.79 to -0.08, p = 0.04, level of evidence: low), and increased PaO2/FiO2 (MD: 34.78, 95% CI 8.94 to 60.61, p = 0.008, level of evidence: low). Conclusions: This meta-analysis demonstrated that methylene blue administration was associated with an increased in mean arterial pressure and PaO2/FiO2 ratio, along with a reduction in mortality rates, serum lactate levels, and length of hospital stay. However, substantial degree of heterogeneity and inadequate number of studies with low level of evidence warrant future adequately powered RCTs to affirm our results.
format Article
id doaj-art-4e20902d06a94bb5928a0c60486231f8
institution Kabale University
issn 0104-0014
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Brazilian Journal of Anesthesiology
spelling doaj-art-4e20902d06a94bb5928a0c60486231f82025-02-01T04:11:32ZengElsevierBrazilian Journal of Anesthesiology0104-00142025-01-01751844580The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysisKa Ting Ng0Pei En Kwok1Wei En Lim2Wan Yi Teoh3Mohd Shahnaz Hasan4Mohd Fitry Zainal Abidin5University of Malaya, Department of Anesthesiology, Kuala Lumpur, MalaysiaQuinnipiac University Frank H. Netter School of Medicine, Waterbury Hospital, Department of Surgery, North Haven, United StatesUniversity of Glasgow, Department of Anesthesiology, Glasgow, United KingdomUniversity of Malaya, Department of Anesthesiology, Kuala Lumpur, MalaysiaUniversity of Malaya, Department of Anesthesiology, Kuala Lumpur, MalaysiaUniversity of Malaya, Department of Anesthesiology, Kuala Lumpur, Malaysia; Corresponding author.Objectives: Methylene blue exerts its vasopressor properties by inhibiting nitric oxide-mediated vasodilation. Recent studies have advocated the use of methylene blue as a rescue therapy for patients with septic shock. The primary aim was to investigate the effect of methylene blue on the mean arterial pressure among adult patients with septic shock. Methods: Databases of MEDLINE, EMBASE, and CENTRAL were searched from their inception date until October 2023. Randomized Clinical Trials (RCT) comparing methylene blue and placebo in adults with septic shock were included. Results: Our systematic review included 5 studies (n = 257) for data analysis. As compared to the placebo, our pooled analysis showed that methylene blue significantly increased mean arterial pressure (MD: 1.34 mmHg, 95% CI 0.15 to 2.53, p = 0.03, level of evidence: very low). Patients who were given methylene blue were associated with statistically lower mortality rate (OR = 0.49, 95% CI 0.27 to 0.88, p = 0.02, level of evidence: low), reduced serum lactate levels (MD: -0.76 mmoL.L-1, 95% CI -1.22 to -0.31, p = 0.0009, level of evidence: low), reduced length of hospital stay (MD: -1.94 days, 95% CI -3.79 to -0.08, p = 0.04, level of evidence: low), and increased PaO2/FiO2 (MD: 34.78, 95% CI 8.94 to 60.61, p = 0.008, level of evidence: low). Conclusions: This meta-analysis demonstrated that methylene blue administration was associated with an increased in mean arterial pressure and PaO2/FiO2 ratio, along with a reduction in mortality rates, serum lactate levels, and length of hospital stay. However, substantial degree of heterogeneity and inadequate number of studies with low level of evidence warrant future adequately powered RCTs to affirm our results.http://www.sciencedirect.com/science/article/pii/S0104001424001027Methylene blueSeptic shockNitric oxideLactate levelsMortalitySystematic review
spellingShingle Ka Ting Ng
Pei En Kwok
Wei En Lim
Wan Yi Teoh
Mohd Shahnaz Hasan
Mohd Fitry Zainal Abidin
The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis
Brazilian Journal of Anesthesiology
Methylene blue
Septic shock
Nitric oxide
Lactate levels
Mortality
Systematic review
title The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis
title_full The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis
title_fullStr The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis
title_full_unstemmed The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis
title_short The use of methylene blue in adult patients with septic shock: a systematic review and meta-analysis
title_sort use of methylene blue in adult patients with septic shock a systematic review and meta analysis
topic Methylene blue
Septic shock
Nitric oxide
Lactate levels
Mortality
Systematic review
url http://www.sciencedirect.com/science/article/pii/S0104001424001027
work_keys_str_mv AT katingng theuseofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT peienkwok theuseofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT weienlim theuseofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT wanyiteoh theuseofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT mohdshahnazhasan theuseofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT mohdfitryzainalabidin theuseofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT katingng useofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT peienkwok useofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT weienlim useofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT wanyiteoh useofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT mohdshahnazhasan useofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis
AT mohdfitryzainalabidin useofmethyleneblueinadultpatientswithsepticshockasystematicreviewandmetaanalysis